The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

At a glance: Immunotherapy has redefined cancer treatment, but not all patients experience the same benefit when treated. New research in mice identifies how gut bacteria alter the body’s response to ...

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.

A new study from investigators at the Benson-Henry Institute for Mind/Body Medicine at Massachusetts General Hospital and Beth Israel Deaconess Medical Center finds that eliciting the relaxation ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer… ...

Our educational programs advance Harvard Medical School's core mission to alleviate human suffering by nurturing a diverse group of leaders and future leaders in both clinical care and biomedical ...

25 Shattuck Street Boston, MA 02115 617-432-1000Mission and Values Privacy Policy Digital Accessibility Accessibility Contact HMS Jobs Harvard Medicine magazine Alumni ...

For Rogulja, an associate professor of neurobiology in the Blavatnik Institute at Harvard Medical School, an intriguing aspect of sleep is the loss of consciousness and awareness it brings, as the ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...

A Mammoth Solution Scientists look to extinct genes to protect endangered species, climate ...

This article is part of Harvard Medical School’s continuing coverage of COVID-19. A new study of more than 800,000 people has found that in the U.S., COVID “long haulers” were more likely to be older ...